Clinical Trials Logo

Clinical Trial Summary

The main objective is to compare the mitochondrial dynamic between patients operated for aneurysm of ascending aorta or type A aortic dissection (AAD) or control group


Clinical Trial Description

In an aortic aneurysm process, the alteration of the extracellular matrix (ECM) as well as the apoptosis of the smooth muscle cells are due to inflammatory phenomena and oxydative stress, involving mitochondria which has a key place within cells. Mitochondrial fusion and fission constitute mitochondrial dynamic and are involved in the mechanisms described above. The alteration of mitochondrial dynamics has been demonstrated in many pathologies, in particular neurological, cancer and cardiovascular disease and generally occurs in favor of fission. In a mouse model (FASEB J, 2021, Robert P ), the role of mitochondrial fusion has been demostrated as a protective factor against hypertension in resistance arteries and a deletion of OPA1 (optic Atrophy 1) fusion protein may lead to aneurysm until aortic dissection. The results of this experimental study suggest a role of the alteration of mitochondrial dynamic in the development of aneurysm and aortic dissection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05434481
Study type Interventional
Source University Hospital, Angers
Contact Olivier FOUQUET, Dr
Phone 0241357896
Email olfouquet@chu-angers.fr
Status Recruiting
Phase N/A
Start date September 7, 2022
Completion date September 6, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05754541 - Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(GRAFT Study) N/A
Active, not recruiting NCT03861741 - A Study to Evaluate the Feasibility of Screening Relatives of Patients Affected by Non-Syndromic Thoracic Aortic Diseases N/A
Not yet recruiting NCT04431336 - Young Patient With Aortic Dissection or Aneurysm: A Prospective Observational Cohort Study
Recruiting NCT06336213 - Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients N/A